Fig. 3From: Treatment initiation for parkinson’s disease in Australia 2013–2018: a nation-wide studyProportion of new users who initiated with levodopa, non-ergot dopamine agonists (DA), or anticholinergics stratified by sex and age, (A) < 65 years; B) ≥ 65 yearsBack to article page